This company listing is no longer active
Genocea Biosciences Management
Management criteria checks 2/4
Key information
Chip Clark
Chief executive officer
US$3.8m
Total compensation
| CEO salary percentage | 15.2% |
| CEO tenure | 11.6yrs |
| CEO ownership | 0.05% |
| Management average tenure | 6.6yrs |
| Board average tenure | 8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2022 | n/a | n/a | -US$37m |
| Dec 31 2021 | US$4m | US$571k | -US$33m |
| Sep 30 2021 | n/a | n/a | -US$35m |
| Jun 30 2021 | n/a | n/a | -US$36m |
| Mar 31 2021 | n/a | n/a | -US$43m |
| Dec 31 2020 | US$1m | US$551k | -US$44m |
| Sep 30 2020 | n/a | n/a | -US$38m |
| Jun 30 2020 | n/a | n/a | -US$41m |
| Mar 31 2020 | n/a | n/a | -US$36m |
| Dec 31 2019 | US$1m | US$533k | -US$39m |
| Sep 30 2019 | n/a | n/a | -US$29m |
| Jun 30 2019 | n/a | n/a | -US$30m |
| Mar 31 2019 | n/a | n/a | -US$27m |
| Dec 31 2018 | US$1m | US$515k | -US$28m |
| Sep 30 2018 | n/a | n/a | -US$39m |
| Jun 30 2018 | n/a | n/a | -US$48m |
| Mar 31 2018 | n/a | n/a | -US$59m |
| Dec 31 2017 | US$2m | US$493k | -US$57m |
| Sep 30 2017 | n/a | n/a | -US$62m |
| Jun 30 2017 | n/a | n/a | -US$58m |
| Mar 31 2017 | n/a | n/a | -US$54m |
| Dec 31 2016 | US$1m | US$455k | -US$50m |
| Sep 30 2016 | n/a | n/a | -US$44m |
| Jun 30 2016 | n/a | n/a | -US$41m |
| Mar 31 2016 | n/a | n/a | -US$40m |
| Dec 31 2015 | US$2m | US$427k | -US$42m |
Compensation vs Market: Chip's total compensation ($USD3.75M) is above average for companies of similar size in the German market ($USD411.35K).
Compensation vs Earnings: Chip's compensation has increased whilst the company is unprofitable.
CEO
Chip Clark (53 yo)
11.6yrs
Tenure
US$3,750,857
Compensation
Mr. William D. Clark, M.B.A., also known as Chip, has been an Independent Director at iBio, Inc. since August 26, 2021. He has been the Director, Chief Executive Officer and President at Genocea Bioscience...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 11.6yrs | US$3.75m | 0.048% € 314.6 | |
| Chief Scientific Officer | 6.6yrs | US$1.27m | 0.00087% € 5.7 | |
| CFO & Secretary | 3.5yrs | no data | 0.00051% € 3.3 |
6.6yrs
Average Tenure
50yo
Average Age
Experienced Management: GBI1's management team is seasoned and experienced (6.6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 11.6yrs | US$3.75m | 0.048% € 314.6 | |
| Independent Chairman of the Board | 8yrs | US$120.98k | 0% € 0 | |
| Independent Director | 7.6yrs | US$78.48k | 0% € 0 | |
| Independent Director | 9.5yrs | US$75.88k | 0.0066% € 43.3 | |
| Independent Chairman of Scientific Advisory Board & Director | 15.7yrs | US$66.98k | 0.00043% € 2.8 | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | less than a year | US$61.50k | 0% € 0 | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | less than a year | no data | 0% € 0 |
8.0yrs
Average Tenure
53.5yo
Average Age
Experienced Board: GBI1's board of directors are considered experienced (8 years average tenure).